Issue

Vol. 25 No. 11 (2013): Vol 25 Issue 11

Copyright (c) 2013 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

A Validated Stability Indicating RP-HPLC Method for Nabumetone, Identification and Characterization of Forced Degradation Products of Nabumetone Using LC-MS/MS

https://doi.org/10.14233/ajchem.2013.14319
Sanjay Sawant
Sinhgad Technical Education Society's Smt. Kashibai Navale College of Pharmacy, Kondhwa (Bk.), Pune-411 048, India
Vijaya Barge
PDEA's Seth Govind Raghunath Sable College of Pharmacy, Saswad, Tal-Purandar, Dist-Pune-412 301, India

Corresponding Author(s) : Sanjay Sawant

sawant99@rediffmail.com

Asian Journal of Chemistry, Vol. 25 No. 11 (2013): Vol 25 Issue 11

Abstract

The objective of the present study was to report the stability of novel non-steroidal antiinflammatory drug (NSAID), nabumetone based on the information obtained from forced degradation studies. Nabumetone was subjected to forced hydrolytic, oxidative, photolytic and thermal stress in accordance with the ICH guideline Q1A (R2). The drug showed labiality under only photo-neutral condition by forming a single degradation product. HPLC separation of the drug and the degradation product was achieved on a hypersil gold C18 column (4.6 mm × 250 mm, 5 μm) using an isocratic elution method. The method was extended to LC-MS/MS for characterization of the degradation product and the pathway of decomposition was proposed. Validation of the LC-DAD method was carried out in accordance with ICH guidelines. The method met all required criteria and was applied for analysis of commercially available tablets.

Keywords

Nabumetone Stress degradation studies Stability indicating assay method HPLC LC-MS
Sawant, S., & Barge, V. (2013). A Validated Stability Indicating RP-HPLC Method for Nabumetone, Identification and Characterization of Forced Degradation Products of Nabumetone Using LC-MS/MS. Asian Journal of Chemistry, 25(11), 6203–6208. https://doi.org/10.14233/ajchem.2013.14319
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. ICH, Q1A (R2)-Stability Testing of New Drug Substances and Products, International Conference on Harmonization, IFPMA, Geneva (2003).
  2. WHO-Draft Stability Testing of Active Pharmaceutical Ingredients and Pharmaceutical Products, World Health Organization, Geneva (2007).
  3. CPMP-Note for Guidance on Stability Testing: Stability Testing of Existing Active Substances and Related Finished Products, Committee for Proprietary Medicinal Products, EMEA, London (2002).
  4. TPD-Guidance for Industry Stability Testing of Existing Drug Substances and Products, Therapeutic Products Directorate, Health Canada, Ottawa, ON (2003).
  5. M. Bakshi and S. Singh, J. Pharm. Biomed. Anal., 28, 1011 (2002).
  6. Y. Wu, Biomed. Chromatogr., 14, 384 (2000).
  7. N.M. Davies, Clin. Pharmacokinet., 33, 403 (1997).
  8. O.R. Carryl and R.S. Spangler, Scand. J. Rheumatol., 24, 336 (1995).
  9. G.B.F. Porro, M. Montrone, P.I. Caruso and V. Imbesi,Am. J. Gastroenterol., 90, 1485 (1995).
  10. W. Bensen and A. Zizzo, Can. Family Physician, 44, 101 (1998).
  11. M. Valero and S.M. Costa, J. Photochem. Photobiol. A, 157, 93 (2003).
  12. M. Valero, J. Photochem. Photobiol. A, 163, 159 (2004).
  13. N. Sethi,A. Anand, K.K. Chandrul, G. Jain and K.S. Srinivas, J. Chromatogr. Sci., 50, 85 (2012).
  14. S. Singh and M. Bakshi, Pharm. Technol., pp. 1-14 (2000).
  15. ICH, Q2 (R1)-Validation of Analytical Procedures- Text and Methodology, International Conference on Harmonization Geneva, Switzerland (2005).
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 1 Download : 0